PainTEQ Raises Funds to Support SI Joint Fusion

PainTEQ closed $35 million in non-dilutive growth capital backed by its intellectual property portfolio from a lending vehicle managed by MVolution Partners.

Net proceeds from this IP-backed debt financing will be used to expand the commercialization of LinQ, PainTEQ’s implantable sacroiliac (SI) joint stabilization system, as well as...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us